Life Sciences Entrepreneurship Speaker Series: Dr. Simon Pimstone, Sept 28th

Published on Monday, September 21, 2015


The Life Sciences Institute is proud to have Dr. Simon Pimstone, Founder, President & Chief Executive Officer, Xenon Pharmaceuticals Inc speak at their upcoming event! Dr. Pimstone will be interviewed by LSI-GSA Career Development VP, Anna D’souza, about his extraordinary career as an entrepreneur. From being co-founder of Xenon Pharmaceuticals Inc. in 1996 to the decision to go public in 2014 and every step along the way.

The talk will be followed by an optional 1-hour mentorship lunch, where attendees can meet the presenter and get feedback on their own entrepreneurship ideas. Registration is required only for the lunch, and closes September 22nd.

This event is free and open to all. Bring a friend.

Date: Monday, September 28, 2015 Time: 12:30 – 1:30 pm

Location: LSC3, Life Sciences Centre, 2350 Health Sciences Mall


Dr. Pimstone, MD, PhD, FRCPC is a founder and President & Chief Executive Officer at Xenon Pharmaceuticals Inc., one of Canada’s leading publicly listed biotechnology companies (Nasdaq: XENE). Xenon is engaged in discovering and developing novel pharmaceuticals targeting genes and proteins that underlie human diseases with a major focus on neurological and cardiovascular diseases.

As CEO of Xenon Pharmaceuticals, Dr. Simon Pimstone and his partners have led the Vancouver company on a journey of developing novel drugs that target genetically defined targets. By studying genes responsible for rare and inherited diseases, Xenon has identified highly validated intervention points for new medicines. In other words, going from families to genes and from genes to drugs.

He received his MD from the University of Cape Town and his PhD through the University of Amsterdam. He is an internal medicine specialist (FRCPC) with an interest in cardiovascular disease.

Dr. Pimstone is a consultant physician at the UBC Cardiology Clinic in Vancouver. He is Chairman of the Board of Eupraxia pharmaceuticals, was past Chairman of the Providence Healthcare Research Institute, and of Life Sciences British Columbia and is the founder and Principal Investigator on a new provincial project called SAVE BC, the Study to Avoid cardioVascular Disease in British Columbia.

In 2005 he received the Business in Vancouver Top 40 under 40 Award and in 2004 the Globe & Mail’s Canadian Top 40 Under 40 Award. Dr. Pimstone is the author of numerous peer-reviewed publications and is also a regular guest speaker at international scientific meetings and healthcare conferences.